Can blood glucose self-monitoring improve treatment outcomes in type 2 diabetes?

Diabetes Research and Clinical Practice

Volumn 82, Issue SUPPL. 2, 2008, Pages

  Varanauskiene, Egle ^a  

^a KAUNAS UNIVERSITY OF MEDICINE HOSPITAL   (Lithuania)

Author keywords

Postprandial glycemia; Self monitoring of blood glucose; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ARTICLE; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR RISK; GLUCOSE BLOOD LEVEL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; QUALITY OF LIFE; TREATMENT OUTCOME;

BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERGLYCEMIA;

EID: 56949096654     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.09.025     Document Type: Article

References (61)

1. International Diabetes Federation (IDF), Diabetes Atlas, 3rd edition, 2006.
2. Kannel W.B., and McGee D.L. Diabetes and cardiovascular diseases: the Framingham Study. JAMA 241 (1979) 2035-2038
3. Gupta A., Joshi S., Kaushal M., Bansal P., Sharma S.K., and Sharma S. Carotid IMT in healthy control and cardiodiabetic railway population in north india. Poster abstract of diamond APICON 2005. J. Assoc. Phys. India 53 (2005) 322-328
4. Grundy S.M., Benjamin I.J., Burke G.L., Chait A., Eckel R.H., Howard B.V., et al. AHA Scientific Statement: diabetes and cardiovascular disease. Circulation 100 (1999) 1134-1146
5. Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Cardiovascular risk factors clustering with endogenous hyperinsulinemia predict death from coronary heart disease in patients with Type II diabetes. Diabetologia 43 (2000) 148-155
6. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48 (1999) 937-942
7. Coutinho M., Gerstein H.C., Wang Y., and Yusuf S. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95, 783 individuals followed for 12. 4 years. Diabetes Care 22 (1999) 233-240
8. Rathmann W., Giani G., and Mielck A. Cardiovascular risk factors in newly diagnosed abnormal glucose tolerance: comparison of 1997 ADA and WHO criteria. Diabetologia 42 (1999) 1268-1269
9. The Diabetes Control Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977-986
10. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
11. Reichard P., and Pihl M. Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm diabetes intervention study. Diabetes 43 (1994) 313-317
12. Shichiri M., Kishikawa H., Ohkubo Y., and Wake N. Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 23 Suppl. 2 (2000) B21-29
13. Stettler C., Allemann S., Juni P., Cull C.A., Holman R.R., Egger M., et al. Glycemic control and macrovascular disesase in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials. Am. Heart J. 152 1 (2006) 27-38
14. American Diabetes Association. Postprandial blood glucose. Diabetes Care 24 (2001) 775-778
15. Nathan D.M., Buse J.B., Davidson M.B., Heine R.J., Holman R.R., Sherwin R., et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 8 (2006) 1963-1972
16. Sorkin J.D., Muller D.C., Fleg J.L., and Andres R. The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care 28 11 (2005) 2626-2632
17. Ceriello A. The post-prandial state and cardiovascular disease: relevance to diabetes mellitus. Diabetes Metab. Res. Rev. 16 (2000) 125-132
18. Ceriello A. Postprandial hyperglycemia and diabetes complications. Is it time to treat?. Diabetes 54 (2005) 1-7
19. Ceriello A., Bortolotti N., Motz E., Pieri C., and Marra M. Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia. Metabolism 48 (1999) 1503-1508
20. Ceriello A., and Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 816-823
21. International Diabetes Federation. Guideline for management of postmeal glucose, 2007.
22. Esposito K., Ciotola M., Carleo D., Schisano B., Sardelli L., Tommaso D.D., et al. Postmeal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes. J Clin. Endocrin. Metab. 15 (January) (2008) 1-21
23. Cavalot F., Petrelli A., Traversa M., Bonomo K., Fiora E., Conti M., et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J. Clin. Endocrinol. Metab. 91 (2006) 813-819
24. Pistrosh F., Reismann E., Wildbrett J., Koehler C., and Hanefeld M. Relationship between diurnal blood pressure variation and diurnal blood glucose levels in type 2 diabetic patients. Am. J. Hypertens. 20 (2007) 541-545
25. Iijima R., Nakajima R., Sugi K., and Nakamura M. Improvement of postprandial hyperglycemia has a positive impact on epicardial flow of entire coronary tree in acute coronary syndromes patients. Circ. J. 71 (2007) 1079-1085
26. Donahue R.P., Abbott R.D., Reed D.M., and Yano K. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program. Diabetes 36 (1987) 689-692
27. Hanefeld M., Fisher S., Julius U., Schulze J., Schwanebeck U., Schmechel H., et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39 (1996) 1577-1583
28. Barrett-Connor E., and Ferrara A. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study. Diabetes Care 21 (1998) 1236-1239
29. Balkau B., Shipley M., Jarrett R.J., Pyoralla K., Pyoralla M., Forhan A., et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-Year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 21 3 (1998) 360-370
30. Tominaga M., Eguchi H., Manaka H., Igarashi K., Kato T., and Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22 (1999) 920-924
31. De Vegt F., Dekker J.M., Ruhe H.G., Stehouwer C.D.A., Nijpels G.B.L.M., and Heine R.J. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42 (1999) 926-931
32. The DECODE Study Group EDEG. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354 (1999) 617-621 Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe
33. World Health Organization. Cardiovascular risk profile assessment in glucose-intolerant Asian individuals. An evaluation of the World Health Organization two-step strategy: the DECODA Study. Diabet. Med. 19 (2002) 549-557 Diabetes epidemiology: collaborative analysis of diagnostic criteria in Asia.
34. Chiasson J.L., Josse R.G., Gornis R., Hanefeld M., Karasik A., and Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359 (2002) 2072-2077
35. Hanefeld M., Chiasson J.L., Koehler C., Henkel E., Schaper F., and Ternelkova-Kurktschiev T. Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke 35 (2004) 1073-1078
36. Manzella D., Grella R., Abbatecola A.M., and Paolisso G. Repaglinide administration improves brachial reactivity in type 2 diabetic patients. Diabetes Care 28 (2005) 366-371
37. Hanefeld M., Cagatay M., Petrowitsch T., Neuser D., Petzinna D., and Rupp M. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur. Heart J. 25 (2004) 10-16
38. Kirkman S.M., Shankar R.R., Shankar S., Shen C., Brizendine E., Baron A., et al. Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes. Diabetes Care 29 9 (2006) 2095-2101
39. Saudek C.D., Derr R.L., and Kalyani R.R. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA 295 14 (2006) 1688-1697
40. Koenig R.J., Peterson C.M., Jones R.L., Saudek C., Lehrman M., and Cerami A. Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N. Engl. J. Med. 295 (1976) 417-420
41. Davie S.J., Gould B.J., and Yudkin J.S. Effect of vitamin C on glycosylation of proteins. Diabetes 41 (1992) 167-173
42. Ceriello A., Giugliano D., Quotraro A., Donzela C., Dipalo G., and Lefebwre P.I. Vitamin E reduction of protein glycosylation in diabetes: new prospect for prevention of diabetic complications?. Diabetes Care 14 (1991) 68-72
43. Derr R., Garrett E., Stacy G.A., and Saudek C.D. Is HbA (1c) affected by glycemic instability?. Diabetes Care 26 (2003) 2728-2733
44. Bonora E., Corrao G., Bagnardi V., Ceriello A., Comaschi M., Montanari P., et al. Prevalence and correlates of post-prandial hyperglycemia in a large sample of patients with type 2 diabetes mellitus. Diabetologia 49 5 (2006) 846-854
45. Faas A., Schellevis F.G., and Van Eijk J.T. The efficacy of self-monitoring of blood glucose in NIDDM subjects: a criteria based literature review. Diabetes Care 20 (1997) 1482-1486
46. Coster S., Gulliford M.C., Seed P.T., Powrie J.K., and Swaminathan R. Self-monitoring in type 2 diabetes mellitus: a meta-analysis. Diabet. Med. 17 (2000) 755-761
47. Ipp E., Aquino R.L., and Christenson P. Point: self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: the sanguine approach. Diabetes Care 28 (2005) 1528-1530
48. Davidson M.B. Counterpoint: self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care 28 (2005) 1531-1533
49. Karter A.J., Ackerson L.M., Darbinian J.A., D'Agostino Jr. R.B., Ferrara A., Liu J., et al. Self-monitoring of blood glucose levels and glycemic control: the Northen California kaiser permanent diabetes registry. Am. J. Med. 111 (2001) 1-9
50. American Diabetes Association. Test of glycemia in diabetes. Diabetes Care 21 Suppl. 1 (1998) S69-S71 Position Statement
51. Murata G.H., Shah J.H., Hoffman R.M., Wendel C.S., Adam K.D., Solvas P.A., et al. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care 26 6 (2003) 1759-1763
52. Martin S., Schneider B., Heinemann L., Lodwig V., Kurth H.J., Kolb H., et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 49 (2006) 271-278
53. Davis W.A., Bruce D.G., and Davis T.M.E. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study. Diabetes Care 29 8 (2006) 1764-1770
54. Tengblad A., Grodzinsky E., Lindstrom K., Molstad S., Borgquist L., and Ostgren C.J. Self-monitoring of blood glucose and glycaemic control in type 2 diabetes. Scand. J. Primary Health Care 25 (2007) 140-146
55. Welschen L.M.C., Bloemendal E., Nijpels G., Dekker J.M., Heine R.J., Stalman W.A.B., et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 28 6 (2005) 1510-1517
56. Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manly S.E., Cull C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000) 405-412
57. Guerci B., Drouin P., Grange V., Bougneres P., Fontaine P., Kerlan V., et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab. 29 (2003) 587-594
58. Muchmore D.B., Springer J., and Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetol. 31 (1994) 215-219
59. Schwedes U., Siebolds M., and Mertes G. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin treated type 2 diabetic patients. Diabetes Care 25 (2002) 1928-1932
60. Weber Ch., Schneider B., Lodwig V., Holm M.V., and Neeser K. Cost impact of blood glucose self-monitoring on complications of type 2 diabetes: a Swiss perspective (ROSSO study No. 11). Swiss Med. Wkly. 137 (2007) 545-550
61. Jansen J.P. Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons. Curr. Med. Res. Opin. 22 4 (2006) 671-681